Veterinary Medicines Information website

FYPERIX COMBO 67 MG/60,3 MG SPOT-ON SOLUTION FOR SMALL DOGS

Authorised
  • Fipronil
  • Methoprene
Download as PDF

Product identification

Medicine name:
FYPERIX COMBO 67 MG/60,3 MG SPOT-ON SOLUTION FOR SMALL DOGS
Active substance:
  • Fipronil
  • Methoprene
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    67.00
    milligram(s)
    /
    1.00
    Pipette
  • Methoprene
    60.30
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 1 pipette.
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 30 pipettes.
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 10 pipettes.
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 6 pipettes.
  • White polypropylene unit-dose pipette with polyethylene or polyoxymethylene closure with spike packaged into laminated triplex bag composed of polyester, aluminium and polyethylene. Cardboard box containing 3 pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • TAD Pharma GmbH
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 117510
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0333/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 14/03/2026
Download
Dutch (PDF)
Published on: 10/06/2025
Download